Skip to content

Member

Tiemo WÖLKEN

S&D · Germany

Group
S&D
Country
Germany
Roll-call participation
74.2 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
96.7 %ⓘ of 4 396 votes where the group had a line · S&D median 96.3 %
More facts (5)
National party
SPD Sozialdemokratische Partei Deutschlands
In office
Since 16 Jul 2024
Against clear line
113 of 4 332 votesⓘ
Committees
ENVI, JURI (substitute), SANT
Member id
185619
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

74.2 %

4 398 of 5 928 roll calls while in office

S&D median: 89.9 % (−15.7 pts)

Chamber median: 90.2 %

With majority line ⓘ

96.7 %

4 253 of 4 396 votes where their group had a line

S&D median: 96.3 % (+0.5 pts)

Against clear line ⓘ

2.6 %

113 of 4 332 votes where their group had a clear line

91 opposite (for ↔ against), 15 abstained against the line, 7 voted for or against when the line was to abstain

Abstention ⓘ

1.3 %

59 of 4 398 votes cast

Participation 74.2 % — S&D median 89.9 %, 138 members.ⓘ
Data as a table
Participation among the 138 members of the S&D with enough votes.
FigureParticipation
Tiemo WÖLKEN74.2 %
S&D median89.9 %
Lowest in the group30.4 %
Highest in the group99.6 %
Members138
With majority line 96.7 % — S&D median 96.3 %, 138 members.ⓘ
Data as a table
With majority line among the 138 members of the S&D with enough votes.
FigureWith majority line
Tiemo WÖLKEN96.7 %
S&D median96.3 %
Lowest in the group81.9 %
Highest in the group99.4 %
Members138
  • Whole term, 5 928 roll-call votes. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 101 to Article 47 48 for, 520 against, 57 abstainedPosition: Against Majority line: Against
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 93, adding text after Article 45 92 for, 496 against, 46 abstainedPosition: Against Majority line: Against
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 92 to Article 45 79 for, 501 against, 53 abstainedPosition: Against Majority line: Against
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 91 to Article 42 54 for, 511 against, 64 abstainedPosition: Against Majority line: Against
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 90 to Article 15 48 for, 521 against, 65 abstainedPosition: Against Majority line: Against
13 Nov 2025Business in Europe: Framework for Income Taxation (BEFIT) Amendment 89 to Article 2 51 for, 509 against, 60 abstainedPosition: Against Majority line: Against
13 Nov 2025Digital Trade Agreement between the European Union and the Republic of Singapore (Resolution) Final vote on the motion for a resolutionAdopted 572 for, 18 against, 41 abstainedPosition: For Majority line: For
13 Nov 2025Digital Trade Agreement between the European Union and the Republic of Singapore Final vote on the draft Council decisionConsent given 515 for, 93 against, 33 abstainedPosition: Abstained ≠ groupMajority line: For
13 Nov 2025Opinion from the Court of Justice on the compatibility with the Treaties of the proposed Agreement on Digital Trade between the European Union and the Republic of Singapore Final vote on the motion for a resolutionRejected 136 for, 432 against, 71 abstainedPosition: For ≠ groupMajority line: Against
13 Nov 2025Exceptional trade measures for countries and territories participating in or linked to the Stabilisation and Association Process Final votePassed 543 for, 72 against, 22 abstainedPosition: For Majority line: For
13 Nov 2025Exceptional trade measures for countries and territories participating in or linked to the Stabilisation and Association Process Amendment 1, adding text after recital 5 73 for, 548 against, 11 abstainedPosition: Against Majority line: Against
13 Nov 2025Exceptional trade measures for countries and territories participating in or linked to the Stabilisation and Association Process Amendment 4 to Article 1 80 for, 544 against, 10 abstainedPosition: Against Majority line: Against
13 Nov 2025Exceptional trade measures for countries and territories participating in or linked to the Stabilisation and Association Process Amendment 2 to Article 1– paragraph 1 106 for, 507 against, 9 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Referral back to committee 426 for, 202 against, 8 abstainedPosition: Against Majority line: Against
13 Nov 2025Exceptional trade measures for countries and territories participating in or linked to the Stabilisation and Association Process Amendment 3 to Article 1 79 for, 539 against, 9 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Final votePassed 382 for, 249 against, 13 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 265 to recital 28 203 for, 423 against, 10 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 228 + 287 (voted as one) to recital 26 360 for, 277 against, 4 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 286 to recital 24 294 for, 337 against, 9 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 227 + 285 (voted as one) to recital 19 364 for, 269 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 260 to recital 19 183 for, 457 against, 3 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 226 + 284 (voted as one) to recital 18 363 for, 276 against, 6 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 259 to recital 18 179 for, 457 against, 3 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 225 + 283 (voted as one) to recital 14 365 for, 271 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 352 to recital 14 181 for, 453 against, 2 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 224 + 282 (voted as one) to recital 12 364 for, 266 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 223 + 281 (voted as one) to recital 9 367 for, 270 against, 6 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 351 to recital 9 186 for, 441 against, 3 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 222 + 280 (voted as one) to recital 7 361 for, 274 against, 8 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 350 to recital 7 181 for, 444 against, 2 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 221 + 279 (voted as one) to recital 5 366 for, 273 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 349 to recital 5 179 for, 450 against, 3 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 394, adding text after recital 2 182 for, 446 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 393 to recital 2 183 for, 445 against, 11 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 254 + 316 + 2 (voted as one) to Article 4 368 for, 271 against, 7 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 116 + 117 + 316 + 1 (voted as one) to Article 4 536 for, 100 against, 9 abstainedPosition: Against ≠ groupMajority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 219 to Article 4 201 for, 426 against, 11 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 217 to Article 4 210 for, 423 against, 4 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 215 to Article 4 211 for, 423 against, 4 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 212 to Article 4 209 for, 422 against, 6 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 210 to Article 4 209 for, 425 against, 4 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 208 to Article 4 207 for, 430 against, 6 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 207 + 266 + 348 (voted as one) to Article 4 251 for, 378 against, 13 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 253 + 315 (voted as one) to Article 4 361 for, 280 against, 6 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 115 to Article 4 238 for, 395 against, 9 abstainedPosition: For Majority line: For
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 205 to Article 4 94 for, 532 against, 12 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 252 + 314 (voted as one) to Article 4 364 for, 270 against, 8 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 251 + 313 (voted as one) to Article 4 364 for, 270 against, 8 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendments 311 + 398 (voted as one) to Article 4 365 for, 276 against, 4 abstainedPosition: Against Majority line: Against
13 Nov 2025Certain corporate sustainability reporting and due diligence requirements Amendment 308 to Article 4 114 for, 522 against, 10 abstainedPosition: Against Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 46 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 2024230
18 Jul 202411
16 Sept 202420
18 Sept 202422
19 Sept 20249291
7 Oct 202420
8 Oct 202410
9 Oct 2024180
10 Oct 202440
21 Oct 202422
22 Oct 20241010
23 Oct 2024129124
24 Oct 20241313
13 Nov 202422
14 Nov 20243634
25 Nov 202420
26 Nov 2024180
27 Nov 20241111
28 Nov 2024570
17 Dec 20241313
18 Dec 20243332
19 Dec 20244544
20 Jan 202520
21 Jan 202511
22 Jan 202522
23 Jan 20254544
10 Feb 202510
11 Feb 20253232
12 Feb 2025109
13 Feb 20253030
10 Mar 202520
11 Mar 202599
12 Mar 2025228223
13 Mar 2025240
31 Mar 202530
1 Apr 20253535
2 Apr 2025251249
3 Apr 2025620
5 May 202550
6 May 20251010
7 May 2025220214
8 May 202510399
21 May 202520
22 May 2025530
16 Jun 202520
17 Jun 20254141
18 Jun 20259189
19 Jun 2025870
7 Jul 202510
8 Jul 20255553
9 Jul 2025134120
10 Jul 2025360
8 Sept 202510
9 Sept 202510190
10 Sept 20253433
11 Sept 2025690
6 Oct 202520
7 Oct 202555
8 Oct 20255554
9 Oct 20256565
20 Oct 202533
21 Oct 20251313
22 Oct 2025186157
23 Oct 2025550
13 Nov 2025267263
24 Nov 202533
25 Nov 20257571
26 Nov 2025100100
27 Nov 20251250
15 Dec 202544
16 Dec 20256665
17 Dec 2025430
18 Dec 2025420
20 Jan 20266767
21 Jan 2026112111
22 Jan 2026580
9 Feb 202620
10 Feb 2026380
11 Feb 2026130
12 Feb 20261410
24 Feb 2026430
9 Mar 202610
10 Mar 2026197195
11 Mar 20266060
12 Mar 20263434
25 Mar 202630
26 Mar 2026690
27 Apr 202620
28 Apr 2026225221
29 Apr 2026296290
30 Apr 2026680
18 May 202640
19 May 202633
20 May 20269693
21 May 20269897
15 Jun 202620
16 Jun 20264036
17 Jun 20261270
18 Jun 2026770
6 Jul 202620
7 Jul 20267267
8 Jul 2026144141
9 Jul 20266765
14 Sept 202610
15 Sept 2026155154
16 Sept 20268077
17 Sept 2026124122

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
René REPASI S&DGermany98 % of 4 172 shared93 %
Gabriele BISCHOFF S&DGermany97 % of 4 319 shared93 %
Tobias CREMER S&DGermany97 % of 4 120 shared93 %
Jens GEIER S&DGermany97 % of 3 908 shared93 %
Katarina BARLEY S&DGermany97 % of 3 157 shared93 %
Vivien COSTANZO S&DGermany97 % of 4 360 shared93 %
Udo BULLMANN S&DGermany97 % of 3 698 shared93 %
Matthias ECKE S&DGermany97 % of 4 089 shared93 %
Birgit SIPPEL S&DGermany97 % of 3 778 shared93 %
Delara BURKHARDT S&DGermany97 % of 3 492 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands90 % of 4 388 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands89 % of 4 390 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 4 146 shared86 %
Ľudovít ÓDOR RenewSlovakia89 % of 4 126 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 653 shared86 %
Lucia YAR RenewSlovakia89 % of 4 350 shared86 %
Charles GOERENS RenewLuxembourg89 % of 4 074 shared86 %
Michal WIEZIK RenewSlovakia89 % of 4 083 shared86 %
Jana TOOM RenewEstonia89 % of 3 745 shared86 %
Dainius ŽALIMAS RenewLithuania89 % of 4 091 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2025 and 2026Shadow rapporteurJURI7 Jul 2026
Replacing S&D shadow rapporteur for the Amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI)Trilogue negotiator6 May 2026
Clean corporate vehiclesRapporteurENVI21 Apr 2026
Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex IShadow rapporteurSANT15 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Opinion rapporteurJURI10 Mar 2026
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024Shadow rapporteurJURI17 Nov 2025
Amending Directives 2000/14/EC, 2011/65/EU, 2013/53/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU, 2014/68/EU and 2014/90/EU of the European Parliament and of the Council as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Amending Regulations (EU) No 765/2008, (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2023/1230, (EU) 2023/1542 and (EU) 2024/1781 as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI23 Jun 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT21 May 2025

Show all 23 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

26 contributions recorded; 2 on behalf of their group; 35 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Stop gold-plating, relieve SMEs: Member States must implement EU legislation without adding extra bureaucracy (topical debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
21 May 2026Need for an adaptation of the EU legal framework on sustainable biofuels (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
20 May 2026Reviewing the ETS system to support European competitiveness (topical debate) Speech · 2 minRead
28 Apr 2026Enforcement of the Digital Markets Act (debate) Speech · 1 minRead
28 Apr 2026Presentation of the Better Regulation and Enforcement Communication (debate) on behalf of S&DSpeech · 1 minRead
8 Oct 2025Europe’s automotive future – reversing the ban on the sale of combustion cars in the EU (topical debate) Speech · 2 minRead

Show all 26 recent contributions

Questions and motions, 20

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
19 May 2026Biofuels and e-fuels in road transport E-10-2026-002077Written questionwith 5 co-authors14 Jul 2026
15 Apr 2026Cali fund – follow up from COP16 UN Convention on Biodiversity O-10-2026-000017Oral questionwith 2 co-authorsNot yet answered
23 Mar 2026MOTION FOR A RESOLUTION on the Commission delegated regulation of 3 February 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for permanent carbon removals activities B-10-2026-0181Motion for a resolutionwith 2 co-authors—
20 Feb 202612 months extension of the Supplementary Protection Certificate within the proposed European Biotech Act P-10-2026-000725Priority written question13 Apr 2026
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
5 Nov 2025Better regulation P-10-2025-004346Priority written question6 Jan 2026
5 Sept 2025A standardised LEZ sticker for cars E-10-2025-003461Written questionwith 3 co-authors8 Dec 2025

Show all 20 questions and motions

Amendments tabled in committee, 75

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT51
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT85
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT66
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT18
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5332
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5335
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5310

Show all 75 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
2 October 2026

Cite as

EU Parl Watch Research (2026). “Tiemo WÖLKEN”. Member record. memberId 185619. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/185619?page=62&seats=all&vscope=all (retrieved 2 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/185619?format=application%2Fld%2Bjson (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-185619,
  author = {{EU Parl Watch Research}},
  title = {{Tiemo WÖLKEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/185619?page=62&seats=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/185619?page=62&seats=all&vscope=all},
  urldate = {2026-10-02},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 185619. Official source: https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}